Immunomodulation of Tumor Vessels: It Takes Two to Tango
- 1 October 2018
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 39 (10) , 801-814
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (APP1042446, APP1122108, APP1141847)
- Cancer Council of Western Australia and Woodside Energy
This publication has 78 references indexed in Scilit:
- CD4+ follicular helper T cell infiltration predicts breast cancer survivalJournal of Clinical Investigation, 2013
- T-Cell Trafficking Facilitated by High Endothelial Venules Is Required for Tumor Control after Regulatory T-Cell DepletionCancer Research, 2012
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapyProceedings of the National Academy of Sciences, 2012
- Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapyProceedings of the National Academy of Sciences, 2012
- Participation of blood vessel cells in human adaptive immune responsesTrends in Immunology, 2012
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cellsJournal of Clinical Investigation, 2011
- Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody ReceptorClinical Cancer Research, 2011
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in miceJournal of Clinical Investigation, 2011
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in miceJournal of Clinical Investigation, 2008